ClinConnect ClinConnect Logo
Search / Trial NCT06894420

Comparison the Analgesic Efficacy of Ultrasonographic Bilateral TAP and Anesthetic Infiltration Into the Surgery Field for Laparoscopic Unilateral TEP Herniorrhaphy

Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · Mar 24, 2025

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Laparoscopic Surgery Inguinal Hernia Postoperative Analgesia Transversus Abdominis Plane (Tap) Block

ClinConnect Summary

This clinical trial is studying two different methods of managing pain after laparoscopic inguinal hernia surgery, which is a common procedure to fix a hernia. The goal is to see which method works better for reducing pain after the operation. In this study, 60 patients will be randomly assigned to one of two groups: one group will receive pain relief through injections in the surgical area, while the other group will receive a special ultrasound-guided technique called a TAP block. Both groups will have their pain levels measured, and the study will also look at how long they stay in the hospital and the overall costs.

To be eligible for this trial, participants need to be between 18 and 65 years old, have a unilateral inguinal hernia (that means it's only on one side), and must be able to cooperate during the study. They should not have a history of certain health issues, allergies, or use specific medications that could interfere with the study. If someone chooses to participate, they can expect to receive careful pain management following their surgery and help with any pain they may experience afterward. This study aims to find the best way to help patients feel comfortable and reduce pain after their hernia surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Consenting patients,
  • She will undergo laparoscopic hernia repair surgery,
  • ASA-I-II,
  • Between the ages of 18 and 65,
  • No history of anticoagulant or antiaggregant drug use,
  • Regional anesthesia is not contraindicated and the anesthesiologist deems -appropriate for regional anesthesia,
  • Under general anesthesia and will undergo laparoscopic surgery,
  • Fully oriented and cooperative,
  • Unilateral inguinal hernia,
  • No previous surgery for inguinal hernia,
  • No incision in the lower abdomen,
  • Not using alcohol and drugs,
  • No preoperative pain and
  • Patients without symptoms of strangulated hernia will be included in the study.
  • Exclusion Criteria:
  • Patients without consent
  • Regional anesthesia is contraindicated,
  • Those who will undergo open abdominal surgery,
  • Not in the appropriate age range,
  • Chronic diseases such as uncontrolled DM and HT,
  • Drug allergy,
  • Taking anticoagulant or antiaggregant drugs,
  • History of chronic analgesic use,
  • Presence of active infection in the area to be blocked,
  • Will not be able to comply with postoperative pain /VAS follow-up,
  • Patients with ASA-III-IV,
  • Patients with bilateral inguinal and scrotal hernias,
  • Patients who have been previously operated for inguinal hernia and have an incision in the lower abdomen,
  • Those with a history of alcohol and drug abuse
  • Preoperative pain and
  • Those with symptoms of strangulated hernia will not be included in this study.

About Başakşehir çam & Sakura City Hospital

Başakşehir Çam & Sakura City Hospital is a leading healthcare institution in Turkey, renowned for its state-of-the-art facilities and commitment to patient-centered care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation across various therapeutic areas. With a multidisciplinary team of experts and a focus on ethical practices, Başakşehir Çam & Sakura City Hospital actively collaborates with industry partners and academic institutions to facilitate cutting-edge clinical trials, aiming to improve treatment outcomes and enhance the overall quality of healthcare.

Locations

Başakşehir, İstanbul, Turkey

Başakşehir, , Turkey

Patients applied

0 patients applied

Trial Officials

EMINE OZCAN, MD

Study Director

Başakşehir Çam ve Sakura Şehir Hastanesi

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported